[Federal Register Volume 78, Number 46 (Friday, March 8, 2013)]
[Notices]
[Pages 15088-15090]
[FR Doc No: 2013-05412]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-69026; File No. SR-OCC-2013-02]

Self-Regulatory Organizations; the Options Clearing Corporation;
Notice of Filing of Proposed Rule Change To Implement a Revised Method
of Calculating Clearing Members' Respective Contributions to OCC's
Clearing Fund

March 4, 2013.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\ and Rule 19b-4 thereunder \2\ notice is hereby given that
on February 19, 2013, The Options Clearing Corporation (``OCC'') filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change as described in Items I, II and III below, which
Items have been prepared primarily by OCC. The Commission is publishing
this notice to solicit comments on the proposed rule change from
interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    OCC proposes to implement a revised method of calculating clearing
members' respective contributions to OCC's clearing fund.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, OCC included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. OCC has prepared summaries, set forth in sections (A),
(B), and (C) below, of the most significant aspects of such
statements.\3\
---------------------------------------------------------------------------

    \3\ The Commission has modified the text of the summaries
prepared by OCC.
---------------------------------------------------------------------------

(A) Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    The purpose of this proposed rule change is to revise OCC's By-Laws
and Rules to implement a revised method of calculating clearing
members' respective contributions to OCC's clearing fund. Currently,
clearing members contribute to the clearing fund in proportion to
average daily open interest, i.e., the total number of cleared
contracts and open positions plus units of stock underlying open stock
loan or borrow positions, over the calendar month preceding the date of
calculation, subject to a $150,000 minimum contribution. There are
exceptions for a small number of Execution-Only Clearing Members,\4\
which are required to make a minimum contribution equal to $150,000
plus the product of $15 per contract multiplied by the average daily
volume of the Execution-Only Clearing Member over the previous calendar
month, and for newly-admitted Clearing Members, whose initial
contribution is fixed by OCC's Board of Directors.
---------------------------------------------------------------------------

    \4\ Article I of OCC's By-Laws define Execution-Only Clearing
Members as those approved to act only as a Clearing Member that
transfers confirmed trades or allocates positions to other Clearing
Members and not to carry positions in its accounts with OCC on a
routine basis.
---------------------------------------------------------------------------

    OCC has developed a new allocation formula that it believes would
more equitably allocate contributions among its clearing members based
on each clearing member's particular activities and use of OCC's
facilities. The revised formula would include the following components:
(1) Open interest; (2) total risk charge; and (3) volume.\5\ The total
risk charge and volume components would be new components of the
allocation formula. The Commission recently noted in publishing its
Clearing Agency Standards, ``registered clearing agencies must evaluate
continually and make appropriate updates and improvements to their
operations and risk management practices * * *.'' \6\ OCC believes that
these proposed enhancements to its existing clearing fund allocation
formula are consistent with this notion of continual evaluation and
refinement.
---------------------------------------------------------------------------

    \5\ Because Execution-Only Clearing Members do not clear their
own trades, the measure of volume applicable to them would be
executed volume rather than cleared volume.
    \6\ Securities Exchange Act Release No. 34-68080 (October 22,
2012), 77 FR 66220 (November 2, 2012).
---------------------------------------------------------------------------

    OCC believes that the 1980 Standards for the Registration of
Clearing Agencies issued by the staff of the Securities and Exchange
Commission supports the idea that clearing members' use of the services
of a clearing agency forms an appropriate basis on which clearing
members should correspondingly be required to participate in the
obligations of the clearing agency's risk management framework.\7\ Use
of a clearing agency by its clearing members may be measured in a
number of ways.
---------------------------------------------------------------------------

    \7\ Securities Exchange Act Release No. 34-16900 (June 17,
1980); 45 FR 41920 (June 23, 1980) (providing in pertinent part that
``all participants utilizing similar clearing agency services * * *
should be required to comply fully with the clearing agency's
internal financial and operational rules such as clearing fund
deposits, mark-to-the-market payments and margin deposits related to
the service used'').
---------------------------------------------------------------------------

    OCC believes that its proposed allocation formula is preferable to
its current formula because, by incorporating measurements of volume
and certain risk charges, it would apportion contributions based on
more sophisticated measurements of clearing members' usage of OCC's
facilities. OCC believes that clearing member volume and risk charges
would recognize demands on OCC's services and facilities that are not
captured by open interest alone. OCC believes that the new formula
would incorporate open interest, total risk charge, and volume, in
proportions that are designed to equitably allocate clearing fund
requirements in light of these additional demands. Specifically, open
interest, total risk charge, and volume would have weightings of 50%,
35%, and 15%, respectively. OCC contemplated alternative weightings in
its decision to propose this particular allocation method but believes
that the proposed formula is appropriate because it would give
significant weight to the new volume and risk charge components and tie
allocations more closely to demands placed by clearing members on OCC's
facilities. While the revised formula would result in significant
reallocations of contributions, OCC does not expect that it would
unduly burden those clearing members anticipated to experience
increased contributions.
    OCC believes it is appropriate for open interest to continue to
serve as the most heavily weighted component because open interest,
generally speaking, is a measure of a clearing member's overall usage
of OCC's facilities. With respect to open interest, the definition of
open interest in proposed Rule 1001(d) is not identical to the
definition of open interest in existing Rule 1001(b), which OCC
proposes to delete. However, OCC believes that the differences in these
two definitions are not material and are the result of the use of the
defined term ``cleared contract'' in proposed Rule 1001(d) instead of
specifically naming the individual types of contracts that make up
``cleared contracts,'' as well as general updating and restructuring of
the rule provision.
    OCC also believes that risk and volume are relevant factors because
they distinctly measure material aspects of clearance and settlement
activity and therefore a clearing member's use of OCC's resources. Each
clearing

member's contribution to the clearing fund should therefore take these
measures of usage of OCC's facilities into account. OCC notes that
clearing members whose OCC accounts contain positions that are well-
diversified and/or exhibit relatively little exposure to overall market
direction would likely have a smaller required contribution under the
proposed formula. Clearing members exhibiting a relatively large
exposure to market direction, a concentration in contracts that
individually present high amounts of risk, and undiversified accounts
would generally experience a larger required contribution than is the
case under the current formula.
    OCC believes that the inclusion of risk and volume metrics within
OCC's clearing fund allocation formula would generally reflect similar
practices that are already in place at other registered clearing
agencies. OCC believes that these existing allocation practices of
other clearing agencies represent a meaningful benchmark of practices
that are used across the industry. Taking those practices into account,
OCC evaluated the appropriateness of including these mechanisms in its
own allocation formula in a way that is tailored to the nature and
demands of OCC's particular business. OCC understands that one clearing
agency allocates contributions among its affected clearing members
using certain measures of volume and open interest in addition to
considering margin requirements over a given period.\8\ The rules of
another clearing agency provide that clearing member contributions to
its clearing fund are determined according to a wide variety of risk-
based charges meant to account for the ways in which clearing members
utilize its services.\9\
---------------------------------------------------------------------------

    \8\ See CME Clearing Financial Safeguards, (2012) (explaining
that CME Group maintains three separate clearing funds that
correspond to the different asset classes for which it provides
clearance and settlement services and that the allocation method for
each clearing fund is distinct), available at http://www.cmegroup.com/clearing/files/financialsafeguards.pdf.
    \9\ See National Securities Clearing Corporation Rules and
Procedures, (September 4, 2012) Procedure XV. Clearing Fund Formula
and Other Matters (providing that allocation of the clearing fund
contributions for National Securities Clearing Corporation
participants involves risk-based charges that include, but are not
limited to, (1) Value-at-Risk to determine the potential future
exposure of a given portfolio based on historical price movements;
(2) mark-to-market to measure unrealized profit or loss of unsettled
securities positions; (3) a fail charge to account for transactions
that do not settle; and (4) other special charges to address any
volatility or lack of liquidity in a security), available at http://www.dtcc.com/legal/rules_proc/nscc_rules.pdf.
---------------------------------------------------------------------------

    OCC's intends that its proposed total risk charge would measure the
economic significance of the activities of a clearing member. The total
risk charge is equal to the margin requirement, as determined by OCC,
of the accounts of the clearing member exclusive of the net asset value
of those accounts. OCC notes that a range of factors influence the
relationship between the open interest in a clearing member's account
and its associated risk charge. For example, for each clearing member
these factors include, but are not limited to, the types of positions,
number of long positions versus short positions, value of the
securities underlying the contracts, volatility of the underlying,
diversification, number of accounts of the clearing member, and the
extent to which the clearing member's options positions are in-the-
money or out-of-the-money.
    Volume, like open interest, is a measure of a clearing member's
level of usage of OCC's facilities. However, volume is distinct from
open interest in that it is a function of the average turnover of the
positions in the clearing member's account. Therefore, market-making,
high frequency trading, and execution-only services are all examples of
activities that tend to elevate volume relative to open interest. By
contrast, holding long term positions in long term contracts is an
example of activity that would lower a clearing member's volume
relative to its open interest.
    OCC notes that most Clearing Member Groups \10\ will experience a
material change (i.e., an increase or decrease of 10% or greater in the
dollar amount of a Clearing Member Group's aggregated Clearing Fund
requirement) under the new formula. The majority of the Clearing Member
Groups that would experience a material change increase in Clearing
Fund requirements are smaller single firms with lower initial Clearing
Fund requirements. OCC notes that small firms tend to experience an
increase under the new allocation formula for two reasons. First,
smaller firms often have portfolios lacking the diversification that
lowers the risk compared with open interest for larger firms. Second,
firms that have a small fraction of combined open interest, total risk,
and volume, experience increases simply due to the fact that the new
formula adds a clearing fund share on top of the $150,000 minimum as
opposed to instead of it. To allow firms that would face a substantial
increase in their clearing fund requirements adequate time to prepare
for the proposed changes, OCC would provide all clearing members
significant lead time, as described below, before implementing the new
formula and would also use an incremental approach to implementation
that would phase in the percentage weightings applicable to each
component. OCC believes that this approach would provide clearing
members with an important opportunity to secure any additional funds
that they anticipate would be necessary in connection with the
requirements of the new formula or to otherwise modify their
activities, for instance by reducing positions, to manage the impact of
the new formula.
---------------------------------------------------------------------------

    \10\ The term ``Clearing Member Group'' is defined in OCC's By-
Laws as a Clearing Member and any Member Affiliates of such Clearing
Member.
---------------------------------------------------------------------------

    The Clearing Fund requirements under the new allocation formula
will be communicated to the clearing membership prior to the time they
become effective to allow clearing members to review and prepare for
any changes they may experience in their specific Clearing Fund
contribution amount. OCC will contact those clearing members that will
be negatively impacted in a material manner (i.e., an increase of 10%
or greater in the dollar amount of a Clearing Member Group's aggregate
Clearing Fund requirement) to confirm such clearing members have
reviewed the pro forma Clearing Fund requirement numbers and they are
ready to meet the new requirement upon implementation. OCC will then
begin a two stage phase in process for the new Clearing Fund
requirements. The first stage of implementation will occur within 180
calendar days from the date that OCC provides notice to clearing
members of its intent to implement the new formula. At that stage, open
interest, total risk charge, and volume would be applied in the formula
with weightings of 75%, 17.5%, and 7.5%, respectively. The second stage
of implementation and the final weightings of 50%, 35%, and 15% would
then be implemented within 360 days from the same date of the original
notice to clearing members concerning implementation of the new
formula.
    The proposed rule change would also create a defined term in OCC's
By-Laws, ``Futures-Only Affiliated Clearing Member,'' to refer to a
clearing member that is admitted solely for the purpose of clearing
transactions in security futures, commodity futures, and/or futures
options.\11\ While the definition

is new, there would be no substantive change to Section 2 of Article
VIII, under which, if such a clearing member is a member affiliate of
an earlier-admitted clearing member, the clearing member's initial
clearing fund contribution may be fixed by the Board as an amount that
excludes the minimum clearing fund component of $150,000, so long as
the earlier-admitted clearing member already satisfies that
requirement.
---------------------------------------------------------------------------

    \11\ Article VIII, Section 2 of OCC's By-Laws actually refers
also to ``commodity options,'' but options directly on an underlying
commodity--as opposed to options on futures--are now included in
Section 1a(47) of the Commodity Exchange Act to fall within the
definition of a ``swap.'' 7 U.S.C. 1a(47). Since OCC does not
currently have rules for the clearing of swaps, the reference to
commodity options is being omitted from the new definition.
---------------------------------------------------------------------------

    OCC believes that the proposed rule change is consistent with
Section 17A of the Securities Exchange Act of 1934 (``Act'') \12\ and
the rules and regulations thereunder because the proposed modifications
would help ensure that the Rules of OCC ``provide for the equitable
allocation of reasonable dues, fees, and other charges among its
participants'' \13\ and thereby promotes prompt and accurate clearance
and settlement \14\ by enhancing the clearing fund allocation
methodology to continue to account for open interest but also to
additionally use risk charges and volume to account for other exposures
to OCC that result from clearing member activities.
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78q-1.
    \13\ 15 U.S.C. 78q-1(b)(3)(D).
    \14\ 15 U.S.C. 78q-1(b)(3)(F).
---------------------------------------------------------------------------

(B) Self-Regulatory Organization's Statement on Burden on Competition

    OCC does not believe that the proposed rule change would impose a
burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act.

(C) Self-Regulatory Organization's Statement on Comments on the
Proposed Rule Change Received From Members, Participants or Others

    Written comments were not and are not intended to be solicited with
respect to the proposed rule change and none have been received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Within 45 days of the date of publication of this notice in the
Federal Register or within such longer period up to 90 days (i) as the
Commission may designate if it finds such longer period to be
appropriate and publishes its reasons for so finding or (ii) as to
which the self-regulatory organization consents, the Commission will:
    (A) By order approve or disapprove the proposed rule change or
    (B) Institute proceedings to determine whether the proposed rule
change should be disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commissions Internet comment form (http://www.sec.gov/rules/sro.shtml) or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-OCC-2013-02 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-OCC-2013-02. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the public in accordance with the
provisions of 5 U.S.C. 552, will be available for Web site viewing and
printing in the Commission's Public Reference Section, 100 F Street
NE., Washington, DC 20549, on official business days between the hours
of 10:00 a.m. and 3:00 p.m. Copies of such filings will also be
available for inspection and copying at the principal office of OCC and
on OCC's Web site at http://www.theocc.com/components/docs/legal/rules_and_bylaws/sr_occ_13_02.pdf.
    All comments received will be posted without change; the Commission
does not edit personal identifying information from submissions. You
should submit only information that you wish to make available
publicly. All submissions should refer to File Number SR-OCC-2013-02
and should be submitted on or before March 29, 2013.

    For the Commission by the Division of Trading and Markets,
pursuant to delegated authority.\15\
---------------------------------------------------------------------------

    \15\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-05412 Filed 3-7-13; 8:45 am]
BILLING CODE 8011-01-P


UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

WASHINGTON, D.C.  20460

OFFICE OF

PREVENTION, PESTICIDES AND

TOXIC SUBSTANCES

MEMORANDUM

September 5, 2006

SUBJECT:	Trifluralin:  Revised Dietary Risk Estimates Based on the
Addition of Mung Bean Sprouts.

		PC Code:	036101

		DP Barcode:	332202

FROM:	Richard Griffin, Risk Assessor

		Reregistration Branch II

Health Effects Division (HED)

THROUGH:	William Hazel, Branch Chief

		Reregistration Action Branch II

Health Effects Division (7509P)

TO:		John Pates, Chemical Review Manager

		Reregistration Branch II

		Special Review and Reregistration Division (7508P)

The human health risk assessment for trifluralin was completed on May 7,
2004 (R. Griffin memo) for the Tolerance Reassessment Eligibility
Decision (TRED) process.  At that time it was believed that the
tolerance for mung bean sprouts, specifically, was not supported by the
registrant, and the use was deleted from the risk assessment.

The primary registrant for trifluralin, Dow AgroSciences, has
subsequently made it clear to the Agency that this use is, in fact,
still supported and should be included in the dietary risk assessment
for trifluralin.  Although mung bean sprouts are not a significant
consumption item, this memo amends the previous dietary exposure
estimates for trifluralin to fulfill the requirements of FQPA.

Endpoint / Dose

The toxicological endpoints and dose levels that the risk assessment for
trifluralin is based on have not changed since the 5/7/04 risk
assessment.  For clarity, the endpoints/doses are summarized below.

An acute Population Adjusted Dose (aPAD) of 1.0 mg/kg/day was
established for females of child-bearing age based on the No Observable
Adverse Effect Level (NOAEL) of 100 mg/kg/day observed in a rat
developmental study.  A chronic Population Adjusted Dose (cPAD) of 0.024
mg/kg/day was established based on the NOAEL (2.4 mg/kg/day) of a
chronic toxicity study in dogs.  The endpoint(s) of concern are
increased frequency of abnormal stool, decreased body weights, decreased
body weight gains, decreased erythrocytes and hemoglobin, and increased
thrombocytes in males at the study LOAEL.  The Uncertainty Factor is
100x, based on 10x for inter-species extrapolation, 10x for
intra-species variability, and 1x for FQPA considerations.

Trifluralin is classified as a Group C (“possible”) human
carcinogen, and a low dose extrapolation model (Q1*) is applied to the
animal tumor data for quantification of human risk.  The upper-bound
potency factor (Q1*) for trifluralin is 5.8 x 10-3 (mg/kg/day)-1.

Exposure

Trifluralin is a selective pre-emergence herbicide primarily used on
soybean and cotton, but it is also used on many other food commodities.
Tolerances range from 0.05 ppm to 2.0 ppm.  Tolerances for livestock
commodities are not required.  Dietary exposure estimates are refined
based on field trial data, monitoring data (Pesticide Data Program), and
estimates of actual use, or “percent crop treated” estimates.

Non-agricultural uses include turf, ornamentals, and vegetable gardens.

Contamination estimates (EECs) for drinking water were refined by the
use of PRZM-EXAMS modeling, incorporating Percent Cropped Area (PCA)
data.  Dietary exposure estimates for drinking water are based on the
estimates of 7.0 ppb for acute exposure, 0.4 ppb for chronic (cPAD)
exposure, and 0.3 for carcinogenic risk estimates.  EEC estimates are
based on the use parameters of soybean, since soybean is the major use
for trifluralin (and somewhat higher than cotton EECs).

Most of trifluralin’s food tolerances are 0.05 ppm, denoting the
enforcement

method’s Level of Quantitation, or LOQ.  Mung bean sprouts, however,
have a tolerance of 2.0 ppm, which is due to the unique use as a seed
soak versus the typical pre-plant use.  The following risk estimates for
all commodities, including mung bean sprouts, are based on the mung bean
sprout tolerance of 2.0 ppm.

Risk Estimates

 Summary of Dietary Exposure and Risk for Trifluralin

Population Subgroup	Acute Dietary

(99.9 Percentile)	Chronic Dietary	Cancer

	Dietary Exposure (mg/kg/day)	% aPAD	Dietary Exposure

(mg/kg/day)	% cPAD	Dietary Exposure

(mg/kg/day)	Risk

General U.S. Population	--	--	0.000032	0.1	0.000029	1.7E-07

All Infants (< 1 year old)

--	0.000063	0.3	--	--

Children 1-2 years old

--	0.000076	0.3

Children 3-5 years old

--	0.000063	0.3

Children 6-12 years old

--	0.000043	0.2

Youth 13-19 years old

--	0.000026	0.1

Adults 20-49 years old

--	0.000026	0.1

Adults 50+ years old

--	0.000026	0.1

Females 13-49 years old	0.001110	0.1	0.000026	0.1


[Federal Register: January 10, 2008 (Volume 73, Number 7)]
[Proposed Rules]
[Page 1853]
[DOCID:fr10ja08-21]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R09-OAR-2007-1104; FRL-8512-8]

Revisions to the California State Implementation Plan, San
Joaquin Valley Air Pollution Control District and Sacramento
Metropolitan Air Quality Management District

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA is proposing to approve revisions to the San Joaquin
Valley Air Pollution Control District (SJVAPCD) and Sacramento
Metropolitan Air Quality Management District (SMAQMD) portions of the
California State Implementation Plan (SIP). These revisions concern
oxides of nitrogen (NOX) emissions from internal combustion
engines and stationary gas turbines. We are proposing to approve local
rules to regulate these emission sources under the Clean Air Act as
amended in 1990 (CAA or the Act).

DATES: Any comments on this proposal must arrive by February 11, 2008.

ADDRESSES: Submit comments, identified by docket number EPA-R09-OAR-
2007-1104, by one of the following methods:
    1. Federal eRulemaking Portal: http://www.regulations.gov. Follow the on-

line instructions.
    2. E-mail<EMAIL_ADDRESS>    3. Mail or deliver: Andrew Steckel (Air-4), U.S. Environmental
Protection Agency Region IX, 75 Hawthorne Street, San Francisco, CA
94105-3901.
    Instructions: All comments will be included in the public docket
without change and may be made available online at http://www.regulations.gov,

including any personal information provided, unless the comment
includes Confidential Business Information (CBI) or other information
whose disclosure is restricted by statute. Information that you
consider CBI or otherwise protected should be clearly identified as
such and should not be submitted through http://www.regulations.gov or e-mail.

    http://www.regulations.gov is an ``anonymous access'' system, and EPA will

not know your identity or contact information unless you provide it in
the body of your comment. If you send e-mail directly to EPA, your e-
mail address will be automatically captured and included as part of the
public comment. If EPA cannot read your comment due to technical
difficulties and cannot contact you for clarification, EPA may not be
able to consider your comment. Electronic files should avoid the use of
special characters, any form of encryption, and be free of any defects
or viruses.
    Docket: The index to the docket for this action is available
electronically at http://www.regulations.gov and in hard copy at EPA Region

IX, 75 Hawthorne Street, San Francisco, California. While all documents
in the docket are listed in the index, some information may be publicly
available only at the hard copy location (e.g., copyrighted material),
and some may not be publicly available in either location (e.g., CBI).
To inspect the hard copy materials, please schedule an appointment
during normal business hours with the contact listed in the FOR FURTHER
INFORMATION CONTACT section.

FOR FURTHER INFORMATION CONTACT: Francisco D[oacute][ntilde]ez, EPA
Region IX,<PHONE_NUMBER><EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: This proposal addresses the following local
rules: SJVAPCD Rule 4702 and SMAQMD Rule 413. In the Rules and
Regulations section of this Federal Register, we are approving these
local rules in a direct final action without prior proposal because we
believe these SIP revisions are not controversial. If we receive
adverse comments, however, we will publish a timely withdrawal of the
direct final rule and address the comments in subsequent action based
on this proposed rule. Please note that if we receive adverse comment
on an amendment, paragraph, or section of this rule and if that
provision may be severed from the remainder of the rule, we may adopt
as final those provisions of the rule that are not the subject of an
adverse comment.
    We do not plan to open a second comment period, so anyone
interested in commenting should do so at this time. If we do not
receive adverse comments, no further activity is planned. For further
information, please see the direct final action.

    Dated: December 5, 2007.
Jane Diamond,
Acting Regional Administrator, Region IX.
 [FR Doc. E8-174 Filed 1-9-08; 8:45 am]

BILLING CODE 6560-50-P


[Federal Register Volume 79, Number 92 (Tuesday, May 13, 2014)]
[Notices]
[Page 27295]
[FR Doc No: 2014-10883]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

 [Docket No. ER14-1858-000]

Consolidated Power Co., LLC; Supplemental Notice That Initial
Market-Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding of
Consolidated Power Co., LLC's application for market-based rate
authority, with an accompanying rate tariff, noting that such
application includes a request for blanket authorization, under 18 CFR
Part 34, of future issuances of securities and assumptions of
liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR Part 34, of future issuances of securities and assumptions of
liability, is May 27, 2014.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: May 6, 2014.
Kimberly D. Bose,
Secretary.
[FR Doc. 2014-10883 Filed 5-12-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: September 13, 2006 (Volume 71, Number 177)]
[Notices]
[Page 54034]
[DOCID:fr13se06-43]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP99-301-144]

ANR Pipeline Company; Notice of Negotiated Rate Filing

August 29, 2006.
    Take notice that on August 3, 2006, ANR Pipeline Company (ANR)
tendered for filing and approval two negotiated rate service agreements
between ANR and Midland Cogeneration Venture Limited Partnership. ANR
requests the Commission to accept and approve the agreements to be
effective on April 1, 2007, and April 1, 2008, respectively.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-15140 Filed 9-12-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register: December 1, 2010 (Volume 75, Number 230)]
[Notices]
[Page 74736-74737]
[DOCID:fr01de10-81]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

Food Labeling Workshop; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA), Office of Regulatory
Affairs, Southwest Regional Small Business Representative (SWR SBR)
Program, in collaboration with Iowa State University, is announcing a
public workshop entitled ``Food Labeling Workshop.'' This public
workshop is intended to provide information about FDA food labeling
regulations and other related subjects to the regulated industry,
particularly small businesses and startups.
    Date and Time: This public workshop will be held on March 3 and 4,
2011, from 8 a.m. to 5 p.m.
    Location: The public workshop will be held at the Scheman
Conference Center, Lincoln Way and University Avenue, Iowa State
Center, Ames, IA.
    Contact: David Arvelo, Food and Drug Administration, Southwest
Regional Office, 4040 North Central Expressway, suite 900, Dallas, TX
75204,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>, or email:
<EMAIL_ADDRESS>    For information on accommodation options, visit http://
www.fshn.hs.iastate.edu/foodlabel/register.php or contact Dr. Ruth
MacDonald, 2312 Food Sciences Building, Iowa State University, Ames, IA
50011,<PHONE_NUMBER>, FAX:<PHONE_NUMBER>, email<EMAIL_ADDRESS>    Registration: You are encouraged to register by February 21, 2011.
The workshop has a $250 registration fee to cover the cost of
facilities, materials, lunch on day 1, and breaks. There is no
registration fee for FDA employees. Seats are limited; please submit
your registration as soon as possible. Workshop space will be filled in
order of receipt of registration. Those accepted into the workshop will
receive confirmation. Registration will close after the workshop is
filled. Registration at the site is not guaranteed but may be possible
on a space available basis on the day of the public workshop beginning
at 8 a.m. The cost of registration at the site is $350 payable to:
``Iowa State University.'' If you need special accommodations due to a
disability, please contact Dr. Ruth MacDonald (see Contact) at least 14
days in advance.
    Registration Form Instructions: To register, please complete the
online registration form at http://www.fshn.hs.iastate.edu/foodlabel/
register.php, or submit your full name, business or organization name,
complete mailing address, telephone number, email address, optional fax
number, and any special accommodations required due to disability,
along with a check or money order for $250 payable to ``Iowa State
University.'' Mail to: Dr. Ruth MacDonald, Food Science and Human
Nutrition, 2312 Food Sciences Building, Ames, IA 50011.
    Transcripts: Transcripts of the public workshop will not be
available due to the format of this workshop. Requests for workshop
handouts may be obtained through David Arvelo (see Contact).

SUPPLEMENTARY INFORMATION: This public workshop is being held in
response to the large volume of food labeling inquiries from small food
manufacturers and startups originating from the area covered by FDA's
Kansas City District Office. The SWR SBR presents these workshops to
help achieve objectives set forth in section 406 of the Food and Drug
Administration Modernization Act of 1997 (21 U.S.C. 393), which include
working closely with stakeholders and maximizing the availability and
clarity of information to stakeholders and the public. This is
consistent with the purposes of the SBR Program, which are in part to
respond to industry inquiries, develop educational materials, and
sponsor workshops and conferences to provide firms, particularly small
businesses, with firsthand working knowledge of FDA's requirements and
compliance policies. This workshop is

also consistent with the Small Business Regulatory Enforcement Fairness
Act of 1996 (Pub. L. 104-121), as outreach activities by government
agencies to small businesses.
    The goal of this public workshop is to present information that
will enable manufacturers and regulated industry to better comply with
labeling requirements, especially in light of growing concerns about
obesity and food allergens. Information presented will be based on
Agency position as articulated through regulation, compliance policy
guides, and information previously made available to the public. This
is a hands-on workshop. Topics to be discussed at the workshop include:
(1) Mandatory label elements, (2) nutrition labeling requirements, (3)
the Food Allergen Labeling and Consumer Protection Act of 2004, (4)
health and nutrient content claims, (5) special labeling issues such as
exemptions, and (6) current topics on food labeling and nutrition. FDA
expects that participation in this public workshop will provide
regulated industry with greater understanding of the Agency's
regulatory and policy perspectives on food labeling and increase
voluntary compliance with labeling requirements.

    Dated: November 24, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-30191 Filed 11-30-10; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Pages 78167-78169]
[FR Doc No: 2016-26783]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-D-0539]

Clinical Considerations for Investigational Device Exemptions for
Neurological Devices Targeting Disease Progression and Clinical
Outcomes; Guidance for Industry and Food and Drug Administration Staff;
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of the

guidance entitled ``Clinical Considerations for Investigational Device
Exemptions (IDEs) for Neurological Devices Targeting Disease
Progression and Clinical Outcomes.'' The Center for Devices and
Radiological Health (CDRH) developed this guidance to assist sponsors
who intend to submit an IDE to FDA to conduct clinical trials on
medical devices targeting neurological disease progression and
clinically meaningful patient centered outcomes. FDA considered
comments received on the draft guidance and revised the guidance as
appropriate.

DATES: Submit either electronic or written comments on this guidance at
any time. General comments on Agency guidance documents are welcome at
any time.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2016-D-0539 for ``Clinical Considerations for Investigational
Device Exemptions (IDEs) for Neurological Devices Targeting Disease
Progression and Clinical Outcomes.'' Received comments will be placed
in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at http://www.regulations.gov or at
the Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    An electronic copy of the guidance document is available for
download from the Internet. See the SUPPLEMENTARY INFORMATION section
for information on electronic access to the guidance. Submit written
requests for a single hard copy of the guidance document entitled
``Clinical Considerations for Investigational Device Exemptions (IDEs)
for Neurological Devices Targeting Disease Progression and Clinical
Outcomes'' to the Office of the Center Director, Guidance and Policy
Development, Center for Devices and Radiological Health, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5431, Silver
Spring, MD 20993-0002. Send one self-addressed adhesive label to assist
that office in processing your request.

FOR FURTHER INFORMATION CONTACT: Carlos Pe[ntilde]a, Center for Devices
and Radiological Health, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, Rm. 2680, Silver Spring, MD 20993-0002, 301-
796-6610.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA believes that neurological devices intended to slow disease
progression and improve clinical outcomes that are meaningful may
represent a revolutionary option for patients. FDA developed this
guidance to assist sponsors who intend to submit an IDE to FDA to
conduct clinical trials on medical devices targeting neurological
disease progression and clinically meaningful patient-centered
outcomes. The guidance is intended to aid industry and FDA staff in
considering the benefits and risks of medical devices that target
either the cause or progression of the neurological disorder or
condition such as Alzheimer's disease, Parkinson's disease, or Primary
Dystonia, rather than their symptoms. It is intended to apply to
neurological medical devices that are designed to slow, stop, or
reverse the progression of disease and result in clinically meaningful
patient outcomes. This guidance provides general study design
considerations for clinical trials that investigate neurological
devices using biological markers and clinical outcome assessments. A
draft guidance regarding general study design considerations for
clinical trials that investigate neurological devices using biomarkers
and clinical outcome assessments was announced in the Federal Register
on March 7, 2016 (81 FR 11807) and made available for public comment.
The comment period closed on June 6, 2016. FDA reviewed and considered
all public comments received and revised the guidance as appropriate.

II. Significance of Guidance

    This guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents the
current thinking of FDA on ``Clinical Considerations for
Investigational Device Exemptions (IDEs) for Neurological Devices
Targeting Disease Progression and Clinical Outcomes.'' It does not
establish any rights for any person and is not binding on FDA or the
public. You can use an alternative approach if it satisfies the
requirements of the applicable statutes and regulations.

III. Electronic Access

    Persons interested in obtaining a copy of the guidance may do so by
downloading an electronic copy from the Internet. A search capability
for all Center for Devices and Radiological Health guidance documents
is available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm. Guidance
documents are also available at http://www.regulations.gov. Persons
unable to download an electronic copy of ``Clinical Considerations for
Investigational Device Exemptions (IDEs) for Neurological Devices
Targeting Disease Progression and Clinical Outcomes'' may send an email
request to<EMAIL_ADDRESS>to receive an electronic copy of
the document. Please use the document number 1500021 to identify the
guidance you are requesting.

IV. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR part 812 have been approved under
OMB control number 0910-0078; the collections of information in 21 CFR
parts 801 and 809 have been approved under OMB control number 0910-
0485; the collections of information in 21 CFR part 50 have been
approved under OMB control number 0910-0755; and the collections of
information in the guidance document entitled ``Request for Feedback on
Medical Device Submissions: The Pre-submission Program and Meetings
With Food and Drug Administration Staff'' have been approved under OMB
control number 0910-0756.

    Dated: November 1, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-26783 Filed 11-4-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 213 (Monday, November 6, 2023)]
[Notices]
[Pages 76201-76202]
[FR Doc No: 2023-24486]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings #3

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER10-2135-017; ER10-2124-026.
    Applicants: Spring Canyon Energy LLC, Spindle Hill Energy LLC.
    Description: Notice of Change in Status of Spindle Hill Energy LLC,
et al.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5246.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER10-2881-041; ER10-2882-041; ER10-2883-039; ER10-
2884-039; ER16-2509-010; ER17-2400-011; ER17-2401-011; ER17-2403-011;
ER17-2404-011.
    Applicants: SP Sandhills Solar, LLC, SP Pawpaw Solar, LLC, SP
Decatur Parkway Solar, LLC, SP Butler Solar, LLC, Rutherford Farm, LLC,
Georgia Power Company, Mississippi Power Company, Southern Power
Company, Alabama Power Company.
    Description: Notice of Non-Material Change in Status of Alabama
Power Company, et al.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5241.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER10-3050-013; ER10-3053-013.
    Applicants: Whitewater Hill Wind Partners, LLC, Cabazon Wind
Partners, LLC.
    Description: Notice of Non-Material Change in Status of Cabazon
Wind Partners, LLC, et al.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5227.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER21-9-005; ER21-86-005; ER21-88-005.
    Applicants: Orange County Energy Storage 3 LLC, Orange County
Energy Storage 2 LLC, Henrietta D Energy Storage LLC.
    Description: Notice of Non-Material Change in Status of Henrietta D
Energy Storage LLC, et al.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5248.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER21-136-005.
    Applicants: Flat Ridge 3 Wind Energy, LLC.
    Description: Notice of Change in Status of Flat Ridge 3 Wind
Energy, LLC.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5243.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER21-330-004.
    Applicants: Specialty Products US, LLC.
    Description: Notice of Change in Status of Specialty Products US,
LLC.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5245.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER21-2137-009.
    Applicants: IR Energy Management LLC.
    Description: Notice of Change in Status of IR Energy Management
LLC.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5225.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER24-269-000.
    Applicants: NSTAR Electric Company.
    Description: Initial rate filing: NSTAR-HQUS Transfer Agreement
(ENE Use Rights) to be effective 11/26/2023.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5204.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER24-270-000.
    Applicants: Southwest Power Pool, Inc.
    Description: Sec.  205(d) Rate Filing: Revisions to Attachment AE
to Clarify Resource/Load Aggregation to be effective 1/3/2024.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5219.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER24-271-000.
    Applicants: Southwestern Public Service Company, Southwest Power
Pool, Inc.
    Description: Sec.  205(d) Rate Filing: Southwestern Public Service
Company submits tariff filing per 35.13(a)(2)(iii):

SPS Formula Rate Revisions to Incorporate Changes Accepted in ER23-2845
to be effective 1/1/2023.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5240.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER24-272-000.
    Applicants: ISO New England Inc., The United Illuminating Company.
    Description: Sec.  205(d) Rate Filing: ISO New England Inc. submits
tariff filing per 35.13(a)(2)(iii): UI; Req for Approval of Updated
Depreciation Rates & Rev. to Append D of Att F to be effective 9/1/
2023.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5244.
    Comment Date: 5 p.m. ET 11/21/23.

    Docket Numbers: ER24-273-000.
    Applicants: Goleta Energy Storage, LLC.
    Description: Compliance filing: Notice of Non-Material Change in
Status and Revised Market-Based Rate Tariff to be effective 11/1/2023.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5249.
    Comment Date: 5 p.m. ET 11/21/23.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES23-14-000.
    Applicants: Transource Maryland, LLC, Transource Missouri, LLC,
Transource Oklahoma, LLC, Transource Pennsylvania, LLC, Transource West
Virginia, LLC.
    Description: Report of Securities Issued of Transource
Pennsylvania, LLC.
    Filed Date: 10/31/23.
    Accession Number: 20231031-5222.
    Comment Date: 5 p.m. ET 11/21/23.

    Take notice that the Commission received the following electric
reliability filings

    Docket Numbers: RD24-1-000.
    Applicants: North American Electric Reliability Corporation.
    Description: North American Electric Reliability Corporation
submits Petition for Approval of Proposed Reliability Standards EOP-
011-4 and TOP-002-5 and Request for Expedited Action.
    Filed Date: 10/30/23.
    Accession Number: 20231030-5285.
    Comment Date: 5 p.m. ET 11/30/23.

    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    Any person desiring to intervene, to protest, or to answer a
complaint in any of the above proceedings must file in accordance with
Rules 211, 214, or 206 of the Commission's Regulations (18 CFR 385.211,
385.214, or 385.206) on or before 5:00 p.m. Eastern time on the
specified comment date. Protests may be considered, but intervention is
necessary to become a party to the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.
    The Commission's Office of Public Participation (OPP) supports
meaningful public engagement and participation in Commission
proceedings. OPP can help members of the public, including landowners,
environmental justice communities, Tribal members and others, access
publicly available information and navigate Commission processes. For
public inquiries and assistance with making filings such as
interventions, comments, or requests for rehearing, the public is
encouraged to contact OPP at<PHONE_NUMBER> or [email protected].

    Dated: October 31, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-24486 Filed 11-3-23; 8:45 am]
BILLING CODE 6717-01-P


To comment on the Agency's need for this information, the accuracy of the provided burden estimates, and any suggested methods for minimizing respondent burden, including the use of automated collection techniques, EPA has established a public docket for this ICR under Docket ID Number EPA-HQ-OW-2011-0443, which is available for online viewing at www.regulations.gov, or in person viewing at the Water Docket in the EPA Docket Center (EPA/DC), WJC West, Room 3334, 1301 Constitution Ave., NW, Washington, DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Reading Room is<PHONE_NUMBER>, and the telephone number for the Water Docket is<PHONE_NUMBER>. An electronic version of the public docket is available at www.regulations.gov. This site can be used to submit or view public comments, to access the index listing of the contents of the public docket, and to access those documents in the public docket that are available electronically. When in the system, select "search," then key in the Docket ID Number identified above. Also, you can send comments to the Office of Information and Regulatory Affairs, Office of Management and Budget, 725 17th Street, NW, Washington, DC 20503, Attention: Desk Officer for EPA. Please include the EPA Docket ID Number (EPA-HQ-OW-2011-0443) and the OMB Control Number 2040-0090 in any correspondence.